Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Inflammatory mediators in diabetic retinopathy

In English

Författare

Summary, in English

Diabetic retinopathy (DR) is the most feared complication of diabetes with an overall prevalence of 21.9-36.8% and may, if untreated, lead to severe visual disability or blindness. DR is histologically characterized by pericyte and endothelial cell loss, formation of acellular vessel strands, micro-occlusions, progressive ischemia, and finally the appearance of neovascularization and fibrosis. Hyperglycemia in the retina activates pro-inflammatory pathogenetic pathways i.e., the polyol, PKC, hexosamine, and RAS pathways, as well as AGE formation. Molecular changes result in blood flow alterations, formation of reactive oxygen species and oxidative stress, induction of inflammatory signaling systems and inflow of leukocytes, and ultimately altered gene transcription, in turn promoting the biomolecular DR characteristics. This thesis enlightens how established pathways may contribute to inflammation in DR and summarizes the results of five studies. Up-regulation of inflammatory mediators and leukocyte adhesion molecules was demonstrated in serum and eyes of diabetic subjects with both proliferative DR and no or non-proliferative DR in humans. The roles of oxidative stress as well as of inflammation in retinal ischemia-reperfusion were assessed in rats with and without diabetes, while retinal endothelial expression of VCAM-1 and leukocyte accumulation were studied in early diabetes in mice. Dyslipidemia and the anti-inflammatory effects of lipid-modulating compounds as well as an immunoregulating role of TNF-α were also analyzed. These studies support that inflammation, which might be aggravated by dyslipidemia, has a role in early as well as late stages of DR.

Publiceringsår

2010

Språk

Engelska

Publikation/Tidskrift/Serie

Lund University Faculty of Medicine Doctoral Dissertation Series

Volym

2010:1

Dokumenttyp

Doktorsavhandling

Förlag

Faculty of Medicine, Lund University

Ämne

  • Ophthalmology
  • Endocrinology and Diabetes

Nyckelord

  • inflammation
  • dyslipidemia
  • diabetic retinopathy
  • oxidative stress
  • TNF-alpha
  • VCAM-1

Aktiv

Published

Forskningsgrupp

  • Ophthalmology (Malmö)

Handledare

  • Elisabet Agardh
  • Carl-David Agardh

ISBN/ISSN/Övrigt

  • ISSN: 1652-8220
  • ISBN: 978-91-86443-15-3

Försvarsdatum

22 januari 2010

Försvarstid

09:15

Försvarsplats

MFC Jubileumsaulan, Malmö University Hospital, Entrance 59

Opponent

  • Anders Kvanta (Docent)